Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy

PURPOSE: To determine whether the presence of vitreomacular interface abnormalities (VMIA) in patients with diabetic macular oedema (DMO) modifies the response to ranibizumab. METHODS: Medical records and spectral-domain optical coherence tomography (SD-OCT) scans of consecutive patients with centre...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Graefes Arch Clin Exp Ophthalmol
Huvudupphovsmän: Mikhail, Michael, Stewart, Stephen, Seow, Felicia, Hogg, Ruth, Lois, Noemi
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Berlin Heidelberg 2018
Ämnen:
Retinal Disorders
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6060772/
https://ncbi.nlm.nih.gov/pubmed/29779188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00417-018-4009-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk